QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,393 | -$5,481 | -$11,977 | -$4,863 |
| Dep. & Amort. | $36,300,000 | $36 | $0 | $1,250,000 |
| Deferred Tax | $142,604,000 | $0 | $0 | -$1,250,000 |
| Stock-Based Comp. | $1,255 | $2,017 | $9,007 | $283 |
| Change in WC | -$144 | $770 | $174 | $328 |
| Other Non-Cash | -$178,903,566 | -$54 | $1,028 | $3,509 |
| Operating Cash Flow | -$2,848 | -$2,712 | -$1,769 | -$743 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $572 | $0 |
| Stock Issued | $4,009 | $1,403 | $2,221,000,000 | $100,000,000 |
| Stock Repurch. | $0 | $0 | -$2,191,462,000 | -$64,560,000 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,009 | $1,438 | $2,689 | $751 |
| Financing Cash Flow | $4,009 | $1,438 | $3,260 | $751 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,161 | -$1,275 | $1,492 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $225 | $1,500 | $8 | $0 |
| End Cash | $1,386 | $225 | $1,500 | $8 |
| Free Cash Flow | -$2,848 | -$2,712 | -$1,769 | -$743 |